Correlation Between Ideaya Biosciences and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ideaya Biosciences and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ideaya Biosciences and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ideaya Biosciences and Agios Pharm, you can compare the effects of market volatilities on Ideaya Biosciences and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ideaya Biosciences with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ideaya Biosciences and Agios Pharm.

Diversification Opportunities for Ideaya Biosciences and Agios Pharm

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ideaya and Agios is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Ideaya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ideaya Biosciences are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Ideaya Biosciences i.e., Ideaya Biosciences and Agios Pharm go up and down completely randomly.

Pair Corralation between Ideaya Biosciences and Agios Pharm

Given the investment horizon of 90 days Ideaya Biosciences is expected to under-perform the Agios Pharm. In addition to that, Ideaya Biosciences is 1.36 times more volatile than Agios Pharm. It trades about -0.19 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.07 per unit of volatility. If you would invest  3,323  in Agios Pharm on November 22, 2024 and sell it today you would earn a total of  79.00  from holding Agios Pharm or generate 2.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ideaya Biosciences  vs.  Agios Pharm

 Performance 
       Timeline  
Ideaya Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Ideaya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Agios Pharm 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ideaya Biosciences and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ideaya Biosciences and Agios Pharm

The main advantage of trading using opposite Ideaya Biosciences and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ideaya Biosciences position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Ideaya Biosciences and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing